Abbott Laboratories (ABT): Price and Financial Metrics


Abbott Laboratories (ABT): $123.21

-2.62 (-2.08%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ABT POWR Grades


  • Sentiment is the dimension where ABT ranks best; there it ranks ahead of 98.91% of US stocks.
  • The strongest trend for ABT is in Quality, which has been heading up over the past 163 days.
  • ABT ranks lowest in Momentum; there it ranks in the 19th percentile.

ABT Stock Summary

  • ABT has a higher market value than 99.05% of US stocks; more precisely, its current market capitalization is $220,523,067,904.
  • Abbott Laboratories's stock had its IPO on January 1, 1986, making it an older stock than 92.74% of US equities in our set.
  • Over the past twelve months, ABT has reported earnings growth of 99.68%, putting it ahead of 80.01% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Abbott Laboratories are TMO, NKE, CMCSA, ABBV, and NFLX.
  • ABT's SEC filings can be seen here. And to visit Abbott Laboratories's official web site, go to www.abbott.com.

ABT Valuation Summary

  • ABT's price/earnings ratio is 35.1; this is 3.84% lower than that of the median Healthcare stock.
  • Over the past 243 months, ABT's price/sales ratio has gone up 0.3.
  • Over the past 243 months, ABT's price/earnings ratio has gone down 10.1.

Below are key valuation metrics over time for ABT.

Stock Date P/S P/B P/E EV/EBIT
ABT 2021-08-31 5.6 6.6 35.1 30.2
ABT 2021-08-30 5.5 6.6 35.0 30.1
ABT 2021-08-27 5.5 6.5 34.6 29.8
ABT 2021-08-26 5.5 6.5 34.9 30.0
ABT 2021-08-25 5.5 6.5 34.7 29.8
ABT 2021-08-24 5.5 6.5 34.9 30.0

ABT Growth Metrics

    Its year over year cash and equivalents growth rate is now at 138.5%.
  • The 3 year net cashflow from operations growth rate now stands at 105.64%.
  • The 4 year cash and equivalents growth rate now stands at 1.29%.
Over the past 49 months, ABT's revenue has gone up $17,174,000,000.

The table below shows ABT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 42,308 11,264 7,244
2021-06-30 40,233 10,629 6,376
2021-03-31 37,338 9,823 5,724
2020-12-31 34,608 7,901 4,495
2020-09-30 32,221 6,519 3,382
2020-06-30 31,444 6,401 3,110

ABT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ABT has a Quality Grade of B, ranking ahead of 77.76% of graded US stocks.
  • ABT's asset turnover comes in at 0.559 -- ranking 70th of 680 Pharmaceutical Products stocks.
  • DVAX, RARE, and CORT are the stocks whose asset turnover ratios are most correlated with ABT.

The table below shows ABT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.559 0.557 0.230
2021-03-31 0.527 0.568 0.205
2020-12-31 0.499 0.566 0.166
2020-09-30 0.473 0.567 0.135
2020-06-30 0.462 0.576 0.128
2020-03-31 0.473 0.584 0.147

ABT Price Target

For more insight on analysts targets of ABT, see our ABT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $132.05 Average Broker Recommendation 1.48 (Moderate Buy)

ABT Stock Price Chart Interactive Chart >

Price chart for ABT

ABT Price/Volume Stats

Current price $123.21 52-week high $142.60
Prev. close $125.83 52-week low $105.36
Day low $122.35 Volume 950,195
Day high $124.50 Avg. volume 6,408,556
50-day MA $132.12 Dividend yield 1.49%
200-day MA $123.25 Market Cap 217.87B

Abbott Laboratories (ABT) Company Bio


Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013. (Source:Wikipedia)


ABT Latest News Stream


Event/Time News Detail
Loading, please wait...

ABT Latest Social Stream


Loading social stream, please wait...

View Full ABT Social Stream

Latest ABT News From Around the Web

Below are the latest news stories about Abbott Laboratories that investors may wish to consider to help them evaluate ABT as an investment opportunity.

Harrington Investments, INC Buys Pfizer Inc, AerCap Holdings NV, Sells Chubb, Abbott ...

Investment company Harrington Investments, INC (Current Portfolio) buys Pfizer Inc, AerCap Holdings NV, sells Chubb, Abbott Laboratories, JPMorgan Chase, Danaher Corp, Shopify Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Harrington Investments, INC.

Yahoo | January 21, 2022

3 Things About Abbott Laboratories That Smart Investors Know

When it comes to underrated healthcare stocks that smart investors love, Abbott Laboratories (NYSE: ABT) takes the cake. On the contrary, it's exactly Abbott's willingness to compete in these spaces that makes the company one of the sturdiest. Given that Abbott has a market cap of about $238 billion and trailing revenue of $42.3 billion, it shouldn't surprise anyone that the business sometimes struggles to grow as aggressively as a smaller competitor might.

Yahoo | January 21, 2022

Rise in COVID-19 Test Demand to Boost Abbott (ABT) Q4 Earnings

With the latest surge in COVID infections due to the more contagious Omicron variant, Abbott (ABT) is expected to report sequentially stronger diagnostics results for the fourth quarter.

Yahoo | January 21, 2022

Peavine Capital, Llc Buys Abbott Laboratories, The Home Depot Inc, McDonald's Corp

Investment company Peavine Capital, Llc (Current Portfolio) buys Abbott Laboratories, The Home Depot Inc, McDonald's Corp, AbbVie Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Peavine Capital, Llc.

Yahoo | January 21, 2022

Carnegie Capital Asset Management, LLC Buys Coinbase Global Inc, GXO Logistics Inc, Upstart ...

Beachwood, OH, based Investment company Carnegie Capital Asset Management, LLC (Current Portfolio) buys Coinbase Global Inc, GXO Logistics Inc, Upstart Holdings Inc, FuboTV Inc, QuantumScape Corp, sells , Guardant Health Inc, Verizon Communications Inc, Arista Networks Inc, AT&T Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Carnegie Capital Asset Management, LLC.

Yahoo | January 21, 2022

Read More 'ABT' Stories Here

ABT Price Returns

1-mo N/A
3-mo -3.50%
6-mo 2.99%
1-year 10.82%
3-year 81.38%
5-year 232.98%
YTD -12.15%
2021 30.53%
2020 28.04%
2019 22.08%
2018 29.06%
2017 52.03%

ABT Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ABT Dividend History

Continue Researching ABT

Here are a few links from around the web to help you further your research on Abbott Laboratories's stock as an investment opportunity:

Abbott Laboratories (ABT) Stock Price | Nasdaq
Abbott Laboratories (ABT) Stock Quote, History and News - Yahoo Finance
Abbott Laboratories (ABT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.805 seconds.